We are live on ! Find out more
PCM

Panning Capital Management Portfolio holdings

AUM $97.5M
1-Year Est. Return 302.5%
This Fund
S&P 500
This Quarter Est. Return
+0.32%
1 Year Est. Return
+302.5%
3 Year Est. Return
+348.92%
5 Year Est. Return
10 Year Est. Return
AUM
$118M
AUM Growth
-$234M
Cap. Flow
-$260M
Cap. Flow %
-220.16%
Top 10 Hldgs %
100%
Holding
8
New
2
Increased
1
Reduced
Closed
2

Top Buys

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.47M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 1.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
CALL
Apple
AAPL
$4.9T
$76.5M 64.68%
3,200,000
+2,400,000
+300% +$59.6M
ALLY icon
2
CALL
Ally Financial
ALLY
$14B
$8.54M 7.22%
+500,000
New +$8.64M
JAZZ icon
3
Jazz Pharmaceuticals
JAZZ
$15.5B
$1.41M 1.19%
+10,000
New +$1.47M
KMI.WS
4
DELISTED
Kinder Morgan Inc
KMI.WS
$16K 0.01%
1,000,000
FCX icon
5
CALL
Freeport-McMoran
FCX
$83.9B
-1,500,000
Closed -$15.5M
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
-1,300,000
Closed -$267M

Similar funds

Panning Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Panning Capital Management held 8 positions worth $118M, down 66% from $352M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Panning Capital Management withdrew a net $260M in Q2 2016, closing 2 positions.

By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets.

Against the trend, Panning Capital Management opened a new position in Jazz Pharmaceuticals worth $1.41M.

  • Panning Capital Management's largest Q2 2016 buy was Jazz Pharmaceuticals: 10,000 shares worth $1.41M.
  • Panning Capital Management's ten largest holdings make up 100% of its $118M portfolio in Q2 2016.
  • Panning Capital Management opened 2 new positions and closed 2 in Q2 2016.
  • Panning Capital Management's portfolio value fell 66% quarter-over-quarter to $118M.

Based on Panning Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.